HOUSTON, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Kiromic BioPharma, Inc. (OTCQB:KRBP) ("Kiromic" or the "Company") announces that Chief Executive Officer Pietro Bersani, Chief Financial Officer Brian Hungerford and Chief Scientific Officer and Interim Operations Officer Leonardo Mirandola, Ph.D., will participate in the OTC Markets' Life Science Investor Forum in a Fireside Chat format, hosted by VirtualInvestorConferences.com, on March 7th, 2024.
Date: March 7, 2024
Time: 11:00 a.m. Eastern time
Link: https://bit.ly/3OM3m93
Available for 1x1 meetings: March 7, 2024
This will be a live, interactive event where investors are invited to ask the company questions in real-time. An archived webcast will also be available after the event.
Investors are invited to pre-register ...